Sept 14 (Reuters) - Canada's main stock index rose on Monday
as signs of progress in developing a COVID-19 vaccine renewed
hopes for a post-pandemic economic rebound.
* At 9:50 a.m. ET (1350 GMT), the Toronto Stock Exchange's
S&P/TSX composite index was up 122.42 points, or
0.75%, at 16,344.88.
* Canada is signaling it might not compensate major
telecommunications providers, if the federal government bans
equipment made by China's Huawei from 5G networks, setting up a
potential fight over a bill that could hit C$1 billion ($758
* The financials and the industrials sectors
gained 0.6% and 0.9%, respectively.
* The materials sector, which includes precious
and base metal miners and fertilizer companies, added 1.6% as
gold futures rose 0.3% to $1,943 an ounce.
* The energy sector, however, dropped 1.5% as U.S.
crude prices were down 0.9% a barrel, while Brent crude
* On the TSX, 182 issues gained, while 36 declined for a
5.06-to-1 ratio favoring gainers, with 19.97 million shares
* The largest percentage gainers on the TSX were Torex Gold
Resources, which jumped 8.6%, and Dundee Precious
Metals that rose 6.9%.
* Cineplex fell 4.3%, the most on the TSX, followed
by Enerplus Corp that lost 3.6%.
* The most heavily traded shares by volume were Suncor
Energy, Les Ressources Yorbeau Inc and B2Gold
* The TSX posted four new 52-week highs and no new low.
* Across Canadian issues there were 16 new 52-week highs and
six new lows, with total volume of 39.98 million shares traded.
(Reporting by Shashank Nayar in Bengaluru; Editing by Maju